Expressions and clinical significance of varied membrae transport proteins in patients with early non-small cell lung cancer

PAN Hong,LIU De-sen,CHEN Jun,CAO Ji,TANG Bu-jian

DOI: https://doi.org/10.3969/j.issn.1006-5725.2006.18.015

2006-01-01

Abstract:Objective To investigate the expressions and clinical significan ce of permeability glycoprotein(P-gp),multidrug resistance-related protein(MRP),breast cancer resistance protein(BCRP)and lung resistance-related protein(LRP)proteins in patients with early non-small cell lung cancer(NSCLC,such as stage Ⅰand Ⅱ).Methods The tissue microarray technique was used to prepare for tiss ue microarray in 86 cases of NSCLC that received adjuvant chemotherapy after und ergone radical surgery.The expressions of P-gp,MRP,LRP and BCRP proteins were detected using immunohistochemical two-step method.Results The positive rate o f P-gp,MRP,LRP and BCRP in lung cancer tissue were 70.9%,73.3%,79.1%and 39.5 %,respectively.Their expression was not related to NSCLC histological classifi cation(P >0.05).The higher the expressing intensity of MRP and BCRP,the lower t he 3-year survival rate in NSCLC,but there was not significant discrepancy(P >0.05).NSCLC patients with positive P-gp、LRP expression responded more poorly t o chemotherapy than those with negative P-gp,LRP expression(P< 0.05).The expr ession of P-gp and LRP were related to the efficacy and prognosis of chemothera py in early NSCLC.Conclusions Four kinds of membrane transport proteins were ov er expressed in various degrees in lung cancer without chemotherapy.The combine d effects of P-gp and LRP may be a good marker to chose adjuvant chemotherapy i n completely resected stageⅠ、Ⅱnon-small-cell lung cancer.